From Zero Hedge:
Thanks to changes in patent laws implemented in 2012, hedge funds can now challenge patents for the bargain price of just $23,000 in a process that is now far more efficient than it once was. Some funds may be employing the strategy to drive down the prices of biotech stocks they're short.
http://www.zerohedge.com/news/2015-03-21/hedge-funds-exploit-patent-laws-push-down-biotechs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment